Cohort plc (AIM:CHRT)
London
· Delayed Price · Currency is GBP · Price in GBX | Market Cap | 636.62M |
| Revenue (ttm) | 226.47M |
| Net Income (ttm) | 19.40M |
| Shares Out | 45.28M |
| EPS (ttm) | 0.48 |
| PE Ratio | 29.58 |
| Forward PE | 27.28 |
| Dividend | 0.15 (1.09%) |
| Ex-Dividend Date | Jan 9, 2025 |
| Volume | 23,559 |
| Average Volume | 187,812 |
| Open | 1,430.00 |
| Previous Close | 1,406.00 |
| Day's Range | 1,396.00 - 1,430.00 |
| 52-Week Range | 724.21 - 1,444.08 |
| Beta | 0.15 |
| RSI | 62.79 |
| Earnings Date | Jul 17, 2025 |
About Cohort
Cohort plc provides a various products and services in defense, security, and related markets in the United Kingdom, Germany, Portugal, Africa, North and South America, and the Asia Pacific and Africa, and other European countries. It operates through Communications and Intelligence; and Sensors and Effectors segments. The company offers chess dynamic, a surveillance and fire control, such as command, control, communications, computers, intelligence, surveillance, target acquisition, and reconnaissance, as well as combat systems. It provides in... [Read more]
Financial Performance
In 2024, Cohort's revenue was 202.53 million, an increase of 10.85% compared to the previous year's 182.71 million. Earnings were 15.32 million, an increase of 34.87%.
Financial StatementsNews
Cohort plc: High Growth Aerospace And Defense Play With Steep Valuation
Cohort plc has seen significant growth, with revenues up 25% and profits up 68% in the last six months. Learn more about COHTF stock here.
Cohort expands global reach Down Under with new acquisition
Cohort has completed the acquistion of Australia's EM Solutions, enhancing naval defence capabilities after a record year's results
U.S. Global Launches Technology And Aerospace & Defense ETF: Why Its Allocation Makes Sense
The launch of the U.S. Global Technology and Aerospace & Defense ETF (NYSE: WAR) on Dec. 30, 2024, and its subsequent debut on the New York Stock Exchange, is another feather in the cap for U.S. Glob...
Half Year 2025 Cohort PLC Earnings Presentation Transcript
Half Year 2025 Cohort PLC Earnings Presentation Transcript
Half Year 2025 Cohort PLC Analyst presentation Q&A Transcript
Half Year 2025 Cohort PLC Analyst presentation Q&A Transcript
Visa Accelerator Program Africa selects Cohort 3
Nano-Cap Theriva Biologics' Investigational Drug For Transplant-Related Complication Shows Safety In Bone Marrow Transplant Patients
Theriva Biologics announces DSMC approval to proceed to Cohort ... Full story available on Benzinga.com
Hub71 welcomes 21 startups in 15th Cohort to Abu Dhabi that have raised over $130mln in funding
Cohort 15 startups have raised over USD 130 million in capital, with 80 per cent of selected startups headquartered outside the UAE, reinforcing Hub71's ability to attract high-potential international...